Nie, Y.; Shi, L.; Zhang, Y.; Guo, Y.; Gu, H.
Mannose and Hyaluronic Acid Dual-Modified Iron Oxide Enhances Neoantigen-Based Peptide Vaccine Therapy by Polarizing Tumor-Associated Macrophages. Cancers 2022, 14, 5107.
https://doi.org/10.3390/cancers14205107
AMA Style
Nie Y, Shi L, Zhang Y, Guo Y, Gu H.
Mannose and Hyaluronic Acid Dual-Modified Iron Oxide Enhances Neoantigen-Based Peptide Vaccine Therapy by Polarizing Tumor-Associated Macrophages. Cancers. 2022; 14(20):5107.
https://doi.org/10.3390/cancers14205107
Chicago/Turabian Style
Nie, Ying, Lu Shi, Yanan Zhang, Yunfei Guo, and Hongchen Gu.
2022. "Mannose and Hyaluronic Acid Dual-Modified Iron Oxide Enhances Neoantigen-Based Peptide Vaccine Therapy by Polarizing Tumor-Associated Macrophages" Cancers 14, no. 20: 5107.
https://doi.org/10.3390/cancers14205107
APA Style
Nie, Y., Shi, L., Zhang, Y., Guo, Y., & Gu, H.
(2022). Mannose and Hyaluronic Acid Dual-Modified Iron Oxide Enhances Neoantigen-Based Peptide Vaccine Therapy by Polarizing Tumor-Associated Macrophages. Cancers, 14(20), 5107.
https://doi.org/10.3390/cancers14205107